The 20 Best Merkel Cell Carcinoma Doctors Near Me in Fairfax, VA

Dr. Sekwon Jang is a specialty care physician board certified in internal medicine, hematology, and medical oncology. He has a special interest in management of melanoma and other skin cancers including cutaneous lymphoma. Dr. Jang serves as Director of Melanoma and Cutaneous Oncology Therapeutics and Research and Director of Quality at the Inova Schar Cancer Institute. Before joining Inova, Dr. Jang served as Assistant Professor of Medicine at Georgetown University School of Medicine and Co-Chair of melanoma research group at MedStar Georgetown Cancer Network. Dr. Jang believes in a covenant relationship with his patients, and his goal is to provide the best quality patient-centered care in the setting of multidisciplinary collaboration. Dr. Jang is rated as a Distinguished provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, and Eccrine Porocarcinoma.

Dr. Suraj Venna is a board-certified dermatologist and Medical Director of the Inova Melanoma and Skin Cancer Center. He practices at the Inova Schar Cancer Institute in Fairfax, VA, and is fellowship trained in melanoma and cutaneous oncology. He is actively involved in medical student and resident education and is an Associate Professor of Medicine at the University of Virginia School of Medicine. Prior to his position at Inova, Dr. Venna was the founding Medical Director of the Melanoma Program at the Washington Cancer Institute in Washington, DC. The melanoma team was the recipient of the President's Patients First Award, given for outstanding delivery and coordination of care. He was faculty at Georgetown University School of Medicine, where he taught medical students and trained residents in dermatology and was Fellowship Director for the Melanoma and Cutaneous Oncology Program. Dr. Venna's career in academic medicine began at Boston University and then to the University of California, San Francisco at the Mt. Zion Cancer Center, Melanoma Program, where he served as Director of the Pigmented Lesions Clinic. He is actively engaged with dermatologists both on a local and national level. Dr. Venna was on the Executive Committee of the Washington DC Dermatological Society and is also past President of the Society. On a national level, Dr. Venna has served the American Academy of Dermatology on the State Policy Committee and continues to serve on the Pigmented Lesions Subcommittee and was also on the American Society of Clinical Oncology Melanoma Education Committee. In 2019, he received the Melanoma Research Foundation Humanitarian Award. Dr. Venna is rated as a Distinguished provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Atypical Multiple Mole Melanoma Syndrome.

Dr. Jennifer DeSimone is a specialty care physician board certified in dermatology. She joined Inova Medical Group with 5 years of clinical experience. She has a special interest in management of cutaneous lymphomas, skin cancer in organ transplant recipients and other complex skin cancers. Most recently Dr. DeSimone served as a Director of Cutaneous Lymphoma. Dr. DeSimone became interested in lymphomas of the skin because of the rarity of the disease and the need for greater understanding of its origin and development of more effective therapy. Her goal is to help educate her patients about skin cancer etiology, management and importantly, prevention. A native of Northern Virginia, Dr. DeSimone currently resides in Fairfax County with her husband and two children. In her spare time she enjoys cooking, entertaining, and trail running. Dr. Desimone is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Lymphomatoid Papulosis.

Jeffrey Scott is a Dermatologist practicing medicine in Fairfax, Virginia. Dr. Scott is rated as an Advanced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Melanoma, Squamous Cell Skin Carcinoma, and Sunburn.

Andrew Montemarano is a Dermatologist practicing medicine in Fairfax, Virginia. Dr. Montemarano is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Dr. Kevin Choe is a specialty care physician board certified in radiation oncology at Inova Health System. He joined Inova in 2015 and has been practicing since 2005. Prior to joining Inova, Dr. Choe was on the faculty at University of Texas, Southwestern Medical Center in Dallas, TX, where he specialized in high-precision stereotactic radiotherapy. His research focused on elucidating the genetic alterations that contribute to cancer development and progression. He also designed and conducted clinical trials, investigating novel strategies to overcome treatment resistance in aggressive and metastatic cancers. Dr. Choe grew up in Fairfax, VA, and appreciates the opportunity to serve the community he cares deeply for. Dr. Choe is rated as an Advanced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Metastatic Brain Tumor, and Posterior Fossa Tumor.

Dr. Michael J. Eblan is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2016. Prior to joining Radiation Oncology Associates, he completed his internal medicine internship and radiation oncology residency at the University of North Carolina at Chapel Hill. There, he served as chief resident, led quality and safety initiatives to improve patient care, and designed prospective clinical investigations of circulating tumor cells as a novel biomarker for radiation treatment response. During his residency, Dr. Eblan also completed additional training in CyberKnife robotic radiosurgery and earned a Lean Six Sigma Yellow Belt certification. Much of his research has focused on the effects of radiation on normal tissues and the development of nanotherapeutics to improve the efficacy of chemoradiotherapy and immunotherapy at the Carolina Center of Cancer Nanotechnology Excellence. Dr. Eblan is trained in all aspects of radiation oncology and has particular clinical interest in thoracic, gastrointestinal, breast, prostate, brain, head and neck, hematologic, and pediatric malignancies. He is experienced with multiple radiotherapy techniques, including proton beam therapy, volumetric modulated arc therapies, intensity-modulated radiation therapy, stereotactic body radiotherapy, CyberKnife radiosurgery, intraoperative radiotherapy, and prostate and gynecologic brachytherapy, including high-dose-rate brachytherapy. His work has been recognized by the American Society for Radiation Oncology, the American Association for Cancer Research, the Conquer Cancer Foundation and the American Society of Clinical Oncology. Dr. Eblan grew up in Fairfax County and graduated with distinction as an Echols Scholar from the University of Virginia, receiving dual degrees in biology and economics. He then trained at the National Institutes of Health in Bethesda, MD, through a postbaccalaureate Intramural Research Training Award and published numerous research articles on genetic alterations contributing to human disease, including publication in the New England Journal of Medicine. He received his medical degree from the University of Pennsylvania School of Medicine, where he was awarded the Ruth L. Kirschstein National Research Service Award to study cancer biology and proton radiotherapy. Dr. Eblan is rated as an Advanced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.

Dr. Sarah Gao is a specialty care physician board eligible in radiation oncology. She joined Radiation Oncology Associates in 2022. Dr. Gao is trained in all aspects of radiation oncology, and her practice focuses on the treatment of all types of cancers with an additional focus on the treatment of breast, gynecological, and head and neck malignancies. Dr. Gao grew up in California and attended California State University in Los Angeles through the early entrance program, graduating magna cum laude with a degree in biochemistry. She went on to receive her medical degree from Yale School of Medicine in New Haven, CT, where she was a recipient of the Hirsch and Hsiung Fellowship for medical research. She completed her radiation oncology residency at Yale and served as chief resident. Dr. Gao has experience across a variety of treatment modalities including intensity-modulated radiation therapy, volumetric modulated arc therapy, stereotactic body radiotherapy, Gamma Knife radiosurgery, gynecologic brachytherapy, total skin electron therapy and orthovoltage therapy. During her training, Dr. Gao’s research endeavors focused on using data science to further personalize the treatment of cancer patients. She has experience creating and managing clinical databases, performing advanced statistical analyses, and building supervised machine learning models. She has given multiple oral presentations at national meetings and has authored numerous peer-reviewed publications, book chapters and editorials. Dr. Gao sees patients at Inova Schar Cancer Institute in Fairfax, VA, and at Potomac Radiation Oncology in Woodbridge, VA. Outside the clinic, Dr. Gao enjoys reading, listening to music, trying new recipes and spending time with family. Dr. Gao is rated as an Advanced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses HER-2 Positive Breast Cancer, Metastatic Brain Tumor, Prostate Cancer, Familial Prostate Cancer, and Lymphadenectomy.

Dr. Lonika Majithia is currently the Medical Director of Brachytherapy and Director of Educational Programs at Radiation Oncology Associates, and is board certified in radiation oncology. She joined Radiation Oncology Associates in 2016. Her clinical interests include gynecologic, breast, CNS, GI, thoracic and hematologic malignancies. Dr. Majithia is experienced with multiple radiotherapy techniques including volumetric modulated arc therapies (VMAT), intensity modulated radiation therapy (IMRT), stereotactic body radiotherapy, Gamma Knife and CyberKnife Radiosurgery, intra-operative radiotherapy (IORT), eye plaque brachytherapy, and prostate and gynecologic brachytherapy, including High Dose Rate (HDR) brachytherapy. Dr. Majithia grew up in Albuquerque, NM. She graduated magna cum laude from the University of New Mexico with dual bachelor’s degrees in biology and physics. She was awarded the UNM Merit Scholarship and actively participated in physics and basic science research. She completed her medical training at the University of New Mexico where she was elected to the Alpha Omega Alpha Medical Honor Society. She completed her preliminary medicine internship at the Medical College of Wisconsin in Milwaukee, WI and her radiation oncology residency at The Ohio State University in Columbus, OH. She served as Chief Resident during her last year of residency and remained active in academic pursuits including research and medical education. During her residency, she presented multiple abstracts and presentations at the American Society for Radiation Oncology (ASTRO) annual meetings and American Society of Clinical Oncology (ASCO) meetings. She has published book chapters, written retrospective review articles, and assisted in the development of a phase I clinical trial in hematologic malignancies. During her residency, she also completed a master’s degree in medical sciences. Dr. Majithia is rated as an Advanced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Metastatic Brain Tumor, Neuroendocrine Carcinoma of the Cervix, and Cervical Cancer.

Dr. Gopal Bajaj is the President of Radiation Oncology Associates, PC, and the emeritus Chairman and Medical Director of the Department for Advanced Radiation Oncology and Proton Therapy for Inova Schar Cancer Institute, having served in this role from 2014 to 2020. Prior to joining the radiation oncology practice at Inova Fairfax Hospital, he was an instructor in radiation oncology, medical oncology, and otolaryngology head and neck surgery at Johns Hopkins Hospital. His clinical focus and academic interests center on providing high level, multidisciplinary treatment to patients with head and neck malignancies, educating the next generation of medical specialists, exploring novel mechanisms of radiation-associated toxicity management, and working with emerging technologies in radiation oncology. His additional area of interest includes radiation therapy for benign disease, with a specific focus on Dupuytren’s and Ledderhose diseases. Dr. Bajaj oversees one of the nation’s busiest practices for the treatment of Dupuytren’s and Ledderhose diseases with radiotherapy and is actively involved in research, physician training and patient advocacy for these conditions. He presently serves as an Associate Professor of Radiation Oncology for the University of Maryland School of Medicine, Virginia Commonwealth University School of Medicine and the Uniformed Services University of the Health Sciences. Dr. Bajaj was raised in Overland Park, KS, and graduated with honors from the University of Kansas, receiving dual degrees in biology and genetics. He received his medical degree from the University of Kansas School of Medicine, where he was elected to the Alpha Omega Alpha Medical Honor Society. He has also performed cancer research at the Otto-von-Guericke Universität in Magdeburg, Germany, and gastrointestinal oncology training at the University of Amsterdam’s Academish Medisch Centrum. He went on to complete an internal medicine internship at Harvard. Dr. Bajaj is rated as an Advanced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Pleuropulmonary Blastoma, Breast Cancer, and Metastatic Brain Tumor.

Dr. C. Bryce Johnson is a specialty care physician board certified in radiation oncology. He joined Inova Health System in 2021 and has been practicing since 2017. Prior to joining Inova, Dr. Johnson completed his radiation oncology residency at Memorial Sloan Kettering Cancer Center. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Metastatic Brain Tumor, Pleuropulmonary Blastoma, and Familial Prostate Cancer.

Mather Director, Radiation Oncology Research Inova Radiation Oncology Inova Schar CancerDr. Avani Rao is a specialty care physician board certified in radiation oncology who serves as the Director of Research, Proton Therapy Fellowship Director and lead physician in pediatric radiation oncology. She joined Radiation Oncology Associates in 2020. Her areas of interest are pediatric, gynecologic, gastrointestinal and breast malignancies.Dr. Rao graduated from Yale University magna cum laude with a bachelor’s degree in molecular, cellular and developmental biology. She completed medical school, her internal medicine internship and her radiation oncology residency at Johns Hopkins School of Medicine. She was nominated to Alpha Omega Alpha during medical school, and during her residency, Dr. Rao served as Chief Resident. She pursued additional fellowship training at the University of Maryland to gain specific expertise in proton therapy. Dr. Rao has received several awards supporting her research and recognizing her clinical excellence and has published more than 40 peer-reviewed publications. Dr. Rao is board certified in radiation oncology. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Metastatic Brain Tumor, and Prostate Cancer.

Dr. Daniel Kim is a specialty care physician board certified in radiation oncology at Inova Health System. Dr. Kim graduated top of his class from Amherst College with degrees in neuroscience and music, while becoming a four-time All-American tennis athlete and winning the NCAA men’s tennis championship. He graduated with his MD and MBA, with honors, from Harvard. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, Meningioma, and Prostatectomy.

Dr. Jafar Al-Mondhiry is a medical oncologist board certified in medical oncology, hematology and internal medicine. He joined Inova in 2022 and has been practicing since 2015. Prior to joining Inova, Dr. Al-Mondhiry worked as an Assistant Professor of Clinical Medicine for the Norris Comprehensive Cancer Center at the University of Southern California Keck School of Medicine in Los Angeles, CA. Dr. Al-Mondhiry specializes in the treatment of cutaneous malignancies, including melanoma, merkel cell carcinoma, advanced squamous cell and basal cell carcinomas, and cutaneous lymphomas. His clinical research interests focus on new medical therapies for patients with metastatic melanoma, merkel cell carcinoma, and advanced cutaneous squamous cell carcinoma, particularly in the neoadjuvant space. Other areas of interest include medical education, medical ethics, communication skills training (CST), and palliative/supportive care for patients with advanced cancers. He co-leads the ASCO Palliative Care Communities of Practice. Dr. Al-Mondhiry leads the psycho-oncology curriculum for the Inova hematology/oncology fellowship program, engaging fellows in didactic presentations, narrative medicine discussions, CST, and patient support group attendance, highlighting the human aspects of cancer care—for both patients and their oncologists. In his free time, he enjoys running, doing yoga, weightlifting, practicing meditation, podcasting on topics in the medical humanities and creative nonfiction writing with pieces published in many different outlets for medical humanities. He is the father of three wonderful girls. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Mustafa Abugideiri is a Radiation Oncologist practicing medicine in Fairfax, Virginia. Dr. Abugideiri is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

Mather Chair, Radiation Oncology Department Chair and System Division Chief, Inova Radiation Oncology Inova Schar CancerDr. Ashish Chawla is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2011.He received his undergraduate degree from Pennsylvania State University, graduating with honors in biology. He received his medical degree from Thomas Jefferson University in Philadelphia in 1998, where he was elected to the prestigious Alpha Omega Alpha Medical Honor Society. He completed his radiation oncology training at Harvard’s Massachusetts General Hospital in 2003. There, he won awards for scholarly research as a radiation oncology resident. He has published several peer-reviewed articles related to breast, prostate and gastrointestinal cancer management.Prior to joining Radiation Oncology Associates, he served as a radiation oncologist at Anne Arundel Medical Center in Annapolis, MD. There, he helped lead innovative clinical research as the principal investigator for breast cancer protocols with the Radiation Therapy Oncology Group. He also helped lead the cancer center’s stereotactic radiosurgery program and served as cancer liaison for the American College of Surgeons’ Commission on Cancer. He led numerous studies involving partial breast irradiation as well as prostate, central nervous system, and head and neck cancer investigations.Dr. Chawla’s clinical interests include the multidisciplinary management of breast cancer and prostate cancer patients, and he is the Director of the Partial Breast Irradiation Program at Inova Fairfax Hospital. He has expertise in the use of stereotactic radiosurgery and stereotactic body radiotherapy for tumors of the brain, spine and lung. Additional areas of clinical interest include gastrointestinal, lung, head and neck, and brain tumors.Dr. Chawla has been listed in Washingtonian magazine, Northern Virginia Magazine, and U.S. News and World Report as “Top Doctor” for radiation oncology in the Washington, DC, and Northern Virginia areas. Dr. Chawla is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Familial Prostate Cancer, Prostate Cancer, and Pleuropulmonary Blastoma.

Dr. Tobias Chapman is a specialty care physician board certified in radiation oncology. He joined Inova Schar Cancer Institute in 2019 with more than eight years of clinical experience. Prior to joining Inova Schar, he served as faculty at Harvard. Dr. Chapman is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, HER-2 Positive Breast Cancer, and Metastatic Brain Tumor.

David Y. Lee, MD, is a board certified, specialty care physician in general surgery and complex general surgical oncology. Dr. Lee is an assistant professor of surgery in medical education with University of Virginia School of Medicine at Inova Fairfax Medical Campus. He is actively engaged in resident and student education and serves on the medical school's admissions committee. Dr. Lee serves on the editorial board of Annals of Surgical Oncology and is an active member of the Society of Surgical Oncology. He stays up to date on the latest developments in cancer care through participation in professional societies and clinical research. Dr. Lee serves on the hepato-pancreato-biliary disease site committee for the Society of Surgical Oncology and has also served on the gastrointestinal disease work group in the past. Dr. Lee also serves on the Inova Fairfax Hospital Cancer Committee as a surgical representative. Dr. Lee became interested in the surgical care of cancer patients because he wanted to provide personalized compassionate care. His goal is help patients beat cancer through multidisciplinary care. Memberships/Accreditations Fellow, American College of Surgeons Society of Surgical Oncology American Society of Clinical Oncology Society of American Gastrointestinal and Endoscopic Surgeons. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Melanoma, Gastrointestinal Stromal Tumor, Stomach Cancer, Small Bowel Resection, and Pancreatectomy.

Janakiraman Subramanian is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Subramanian is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Dr. Stella Hetelekidis is a specialty care physician board certified in radiation oncology. She joined Inova Health System in 1999 and has been practicing since 1993.Prior to joining Inova, Dr. Hetelekidis practiced at Duke University Hospital in Durham, NC, and the Brigham and Women’s Hospital and Dana Farber Cancer Institute in Boston, MA.Dr. Hetelekidis specializes in breast and gynecologic cancers. She believes in treating every patient like a family member. She helps her patients understand their diagnoses and options, and works together with the patient and her fellow physicians to develop a treatment plan. Dr. Hetelekidis is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Endometrial Cancer, Angiosarcoma, and HER-2 Positive Breast Cancer.